Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
BIN1 Monoclonal Antibody (99D), Invitrogen™
Mouse Monoclonal Antibody
Supplier: Thermo Scientific MA532996
Description
Reconstitution information: Add 1 mL of PBS buffer will yield a concentration of 100 μg/mL.
This gene encodes several isoforms of a nucleocytoplasmic adaptor protein, one of which was initially identified as a MYC-interacting protein with features of a tumor suppressor. Isoforms that are expressed in the central nervous system may be involved in synaptic vesicle endocytosis and may interact with dynamin, synaptojanin, endophilin, and clathrin. Isoforms that are expressed in muscle and ubiquitously expressed isoforms localize to the cytoplasm and nucleus and activate a caspase-independent apoptotic process. Studies in mouse suggest that this gene plays an important role in cardiac muscle development. Alternate splicing of the gene results in ten transcript variants encoding different isoforms. Aberrant splice variants expressed in tumor cell lines have also been described.
Specifications
BIN1 | |
Monoclonal | |
Unconjugated | |
BIN1 | |
Myc box-dependent-interacting protein 1; Amphiphysin II; Amphiphysin-like protein; Bridging integrator 1; Bin1; Amph2, Amphl | |
Mouse | |
100 μg | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG2b |
Immunocytochemistry, Immunohistochemistry (Frozen), Western Blot | |
99D | |
Ascites diluted in 1.2% sodium acetate with 2MG BSA, 2MG BSA and 0.01MG sodium azide, 0.01MG sodium azide | |
O00499, O08539, O08839 | |
Bin1 | |
Recombit polypeptide containing amino acids 189-398 of human Bin1. | |
RUO | |
117028, 274, 30948 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Lyophilized |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction